247 related articles for article (PubMed ID: 34944814)
1. Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer.
Mishra P; Laha D; Grant R; Nilubol N
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944814
[TBL] [Abstract][Full Text] [Related]
2. Novel targeted therapies and immunotherapy for advanced thyroid cancers.
Naoum GE; Morkos M; Kim B; Arafat W
Mol Cancer; 2018 Feb; 17(1):51. PubMed ID: 29455653
[TBL] [Abstract][Full Text] [Related]
3. New Therapies for Advanced Thyroid Cancer.
Laha D; Nilubol N; Boufraqech M
Front Endocrinol (Lausanne); 2020; 11():82. PubMed ID: 32528402
[TBL] [Abstract][Full Text] [Related]
4. Standard and emerging therapies for metastatic differentiated thyroid cancer.
O'Neill CJ; Oucharek J; Learoyd D; Sidhu SB
Oncologist; 2010; 15(2):146-56. PubMed ID: 20142332
[TBL] [Abstract][Full Text] [Related]
5. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
Smith N; Nucera C
J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569
[TBL] [Abstract][Full Text] [Related]
6. Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review.
Anderson RT; Linnehan JE; Tongbram V; Keating K; Wirth LJ
Thyroid; 2013 Apr; 23(4):392-407. PubMed ID: 23294230
[TBL] [Abstract][Full Text] [Related]
7. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.
Kojic KL; Kojic SL; Wiseman SM
Expert Rev Anticancer Ther; 2012 Mar; 12(3):345-57. PubMed ID: 22369326
[TBL] [Abstract][Full Text] [Related]
9. The Significance of BRAFV600E Mutation in Thyroid Cancer in Terms of Novel Targeted Therapies - Overview of Current Knowledge and Studies.
Iva J; Filip G; Martin B; Pavel Ž; Jan Č
Klin Onkol; 2018; 31(5):339-344. PubMed ID: 30541319
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions.
Porter A; Wong DJ
Front Oncol; 2020; 10():592202. PubMed ID: 33569345
[TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer: emerging role for targeted therapies.
Sipos JA; Shah MH
Ther Adv Med Oncol; 2010 Jan; 2(1):3-16. PubMed ID: 21789122
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in advanced differentiated thyroid cancer.
Carneiro RM; Carneiro BA; Agulnik M; Kopp PA; Giles FJ
Cancer Treat Rev; 2015 Sep; 41(8):690-8. PubMed ID: 26105190
[TBL] [Abstract][Full Text] [Related]
13. Targeted Therapy in Thyroid Cancer: State of the Art.
Valerio L; Pieruzzi L; Giani C; Agate L; Bottici V; Lorusso L; Cappagli V; Puleo L; Matrone A; Viola D; Romei C; Ciampi R; Molinaro E; Elisei R
Clin Oncol (R Coll Radiol); 2017 May; 29(5):316-324. PubMed ID: 28318881
[TBL] [Abstract][Full Text] [Related]
14. BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.
Tang KT; Lee CH
J Chin Med Assoc; 2010 Mar; 73(3):113-28. PubMed ID: 20230995
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Kinase Inhibitors in Thyroid Cancers.
Cuomo F; Giani C; Cobellis G
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631627
[TBL] [Abstract][Full Text] [Related]
16. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract][Full Text] [Related]
17. Advances in targeted therapy and biomarker research in thyroid cancer.
Guo M; Sun Y; Wei Y; Xu J; Zhang C
Front Endocrinol (Lausanne); 2024; 15():1372553. PubMed ID: 38501105
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.
Viola D; Valerio L; Molinaro E; Agate L; Bottici V; Biagini A; Lorusso L; Cappagli V; Pieruzzi L; Giani C; Sabini E; Passannati P; Puleo L; Matrone A; Pontillo-Contillo B; Battaglia V; Mazzeo S; Vitti P; Elisei R
Endocr Relat Cancer; 2016 Apr; 23(4):R185-205. PubMed ID: 27207700
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of patients with thyroid cancer.
Nguyen QT; Lee EJ; Huang MG; Park YI; Khullar A; Plodkowski RA
Am Health Drug Benefits; 2015 Feb; 8(1):30-40. PubMed ID: 25964831
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the management of anaplastic thyroid cancer.
De Leo S; Trevisan M; Fugazzola L
Thyroid Res; 2020 Nov; 13(1):17. PubMed ID: 33292371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
